摘要
目的:观察并评价温病名方升降散对初期脓毒症患者中医症候的影响。方法:选择54例初期脓毒症患者,随机分为对照组和中药组,对照组采用脓毒症西医规范化治疗,中药组在对照组基础上予以连续7天口服或鼻饲升降散治疗。两组患者均予以SIRS评分和主要中医临床症状评分。结果:(1)患者SIRS评分与高热、烦躁及腹胀3项中医临床症状评分显著相关。(2)治疗7天与治疗前相比较,两组患者高热、烦躁、腹胀3项中医症状评分均有显著统计学差异(P<0.01),且中药组患者高热、烦躁、腹胀3项中医症状评分和对照组相比有统计学差异(P<0.05)。结论:升降散结合西医规范化治疗初期脓毒症能够明显改善患者的中医临床症状。
Objective： To study the clinical efficacy and mechanism of Shengjiangsan treatment the the early sepsis patients. Methods： We conducted a control study with 54 early sepsis patients. Twenty-six patients in control group were treated with western medicine alone. Twenty-eight patients in treatment group were treated with western medicine combined 7 days＇ Shengjiangsan. The SIRS score were calculated and the Chinese medicine clinical symptoms score were also monitored. Results： Patients＇ SIRS score is related to three Chinese medicine clinical symptoms of high fever, fidget and abdominal distention. After treatment, two groups of patients＇ high fever, fidget and abdominal distention score were statistically significant differences （P〈0.01）. Compared to the control group, the high fever, fidget and abdominal distention score of the Shengjiangsan group were statistically difference （P〈0.05）.Conclusion： Shengjiangsan with Western medicine treatment can improve the Chinese medicine clinical symptoms of the early sepsis patients.
出处
《辽宁中医药大学学报》
CAS
2009年第12期100-102,共3页
Journal of Liaoning University of Traditional Chinese Medicine
关键词
升降散
脓毒症
SIRS评分
中医
Shengjiangsan
sepsis
SIRS score
Chinese medicine
